Blog
RSS FeedPosted by Michael Wonder on 11 Oct 2022
Scotland backs three new uses for MSD’s Keytruda
11 October 2022 - Scotland has become the first country in the UK to back NHS funding for the use ...
Posted by Michael Wonder on 10 Oct 2022
SMC - October 2022 decisions
10 October 2022 - The SMC has today published advice on new medicines for six different conditions. ...
Posted by Michael Wonder on 14 Sep 2022
Jazz Pharmaceuticals receives SMC approval for reimbursement of Sativex
14 September 2022 - Therapy is for the treatment of spasticity due to multiple sclerosis. ...
Posted by Michael Wonder on 13 Sep 2022
Prostate cancer symptoms as new treatment given green light in Scotland
13 September 2022 - A new treatment for advanced prostate cancer has been approved for use in Scotland, giving medical ...
Posted by Michael Wonder on 13 Sep 2022
Scottish Medicines Consortium accepts Theramex’ Bijuve HRT on NHS Scotland
13 September 2022 - The first and only body identical HRT for post-menopausal oestrogen deficiency, Bijuve, has been passed by ...
Posted by Michael Wonder on 12 Sep 2022
The SMC recommends use of Hansa Biopharma's Idefirix (imlifidase) as desensitisation treatment for highly sensitised kidney transplant patients
12 September 2022 - The SMC decision follows the recent positive NICE recommendation for Idefirix in England, Wales and Northern ...
Posted by Michael Wonder on 18 Aug 2022
Chiesi’s Trimbow recommended for use within NHS Scotland
18 August 2022 - The SMC approval brings much needed boost to asthma sufferers across Scotland. ...
Posted by Michael Wonder on 11 Aug 2022
SMC approve Johnson & Johnson’s systemic light chain amyloidosis therapy
10 August 2022 - Newly diagnosed patients will become the first to access systemic light chain amyloidosis treatment in the ...
Posted by Michael Wonder on 08 Aug 2022
SMC - August 2022 decisions
8 August 2022 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 11 Jul 2022
SMC - July 2022 decisions
11 July 2022 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 13 Jun 2022
SMC - June 2022 decisions
13 June 2022 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...
Posted by Michael Wonder on 10 May 2022
First treatment option indicated for CKD in Scotland for 20 years
10 May 2022 - NICE recommendation for Forxiga could entitle 53,000 adults to the new kidney disease therapy ...
Posted by Michael Wonder on 09 May 2022
SMC - May 2022 decisions
9 May 2022 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 11 Apr 2022
SMC - April 2022 decisions
12 April 2022 - Advice on three new medicines for use in conditions including a rare and fatal genetic condition affecting ...
Posted by Michael Wonder on 15 Mar 2022
New access tool launched as part of SMC’s joint work on streamlining patient access to innovative medicines
8 March 2022 - A new UK wide health technology assessment access forum has been developed by partners including the ...